Use of Fractional Factorial Designs in Antiviral Drug Studies
暂无分享,去创建一个
Jian Yang | Chih-Ming Ho | Xianting Ding | Hongquan Xu | Chanelle Hopper | Chih-Ming Ho | Xianting Ding | Hongquan Xu | Jian Yang | Chanelle Hopper
[1] Connie Celum,et al. Herpes simplex virus (HSV) suppression with valacyclovir reduces rectal and blood plasma HIV-1 levels in HIV-1/HSV-2-seropositive men: a randomized, double-blind, placebo-controlled crossover trial. , 2007, The Journal of infectious diseases.
[2] M. Fellous,et al. A protein tyrosine kinase in the interferon α β signaling pathway , 1992, Cell.
[3] G. Ramadori,et al. Ribavirin inhibits DNA, RNA, and protein synthesis in PHA‐stimulated human peripheral blood mononuclear cells: Possible explanation for therapeutic efficacy in patients with chronic HCV infection , 2003, Journal of medical virology.
[4] A. Ricci,et al. Herpes simplex pneumonia: Combination therapy with oral acyclovir and aerosolized ribavirin in an immunocompetent patient. , 2004, Current therapeutic research, clinical and experimental.
[5] Erik De Clercq,et al. Antiviral drugs in current clinical use. , 2004 .
[6] R. Whitley,et al. Herpes simplex virus infections of the central nervous system: therapeutic and diagnostic considerations. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[7] Håvard Jenssen,et al. Lactoferrin and lactoferricin inhibit Herpes simplex 1 and 2 infection and exhibit synergy when combined with acyclovir. , 2003, Antiviral research.
[8] M. Croxson,et al. Herpes simplex encephalitis treated with acyclovir: diagnosis and long term outcome , 1997, Journal of neurology, neurosurgery, and psychiatry.
[9] K. Rosenthal,et al. Multiple mechanisms for HSV-1 induction of interferon α production by peripheral blood mononuclear cells , 2003, Archives of Virology.
[10] Fujie Xu,et al. Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. , 2006, JAMA.
[11] Max D. Morris,et al. A Class of Three-Level Experimental Designs for Response Surface Modeling , 2000, Technometrics.
[12] S Hercberg,et al. Seroprevalence of HSV-1 and HSV-2 infection in the general French population , 2002, Sexually transmitted infections.
[13] Subhajit Biswas,et al. Drug resistance mutations in HSV-1 UL5 selected using a helicase–primase inhibitor: frequency and effects on virus growth and pathogenicity , 2009 .
[14] John Norrie,et al. Longitudinal study of genital infection by herpes simplex virus type 1 in western Scotland over 15 years , 2002, BMJ : British Medical Journal.
[15] Weng Kee Wong,et al. Recent developments in nonregular fractional factorial designs , 2008, 0812.3000.
[16] C. F. Jeff Wu,et al. Optimal Projective Three-Level Designs for Factor Screening and Interaction Detection , 2004, Technometrics.
[17] W. Halford,et al. Alpha/Beta Interferon and Gamma Interferon Synergize To Inhibit the Replication of Herpes Simplex Virus Type 1 , 2002, Journal of Virology.
[18] J. Shaw,et al. Effect of acyclovir [9-(2-hydroxyethoxymethyl)guanine] on Epstein-Barr virus DNA replication , 1980, Journal of virology.